Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy

Immune Checkpoint Blockade: A Strategy to Unleash the Potential of Natural Killer Cells in the Anti-Cancer Therapy

Immune checkpoint inhibitors (ICIs) immunotherapy has represented a breakthrough in cancer treatment. Clinical use of ICIs has shown an acceptable safety profile and promising antitumor activity. Nevertheless, some patients do not obtain clinical benefits after ICIs therapy. In order to improve and...

Full description

Bibliographic Details
Main Authors: Melania Grottoli, Paolo Carrega, Lodovica Zullo, Chiara Dellepiane, Giovanni Rossi, Francesca Parisi, Giulia Barletta, Linda Zinoli, Simona Coco, Angela Alama, Silvia Marconi, Monica Parodi, Paola Orecchia, Sara Bassi, Massimo Vitale, Maria Cristina Mingari, Ulrich Pfeffer, Carlo Genova, Gabriella Pietra
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
NK cells
immuno-checkpoint inhibitors (ICI)
non-small cell lung cancer (NSCLC)
PD-1
Online Access:https://www.mdpi.com/2072-6694/14/20/5046

Internet

https://www.mdpi.com/2072-6694/14/20/5046

Similar Items